BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26067128)

  • 1. Future directions of acute ischaemic stroke therapy.
    Fisher M; Saver JL
    Lancet Neurol; 2015 Jul; 14(7):758-67. PubMed ID: 26067128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities.
    Röther J; Ford GA; Thijs VN
    Cerebrovasc Dis; 2013; 35(4):313-9. PubMed ID: 23615379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging therapy in acute ischemic stroke: are we ready for a new standard of care?
    Mazighi M; Labreuche J
    Stroke; 2011 Apr; 42(4):880-1. PubMed ID: 21372303
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-pharmacological strategies for the treatment of acute ischaemic stroke.
    Hennerici MG; Kern R; Szabo K
    Lancet Neurol; 2013 Jun; 12(6):572-84. PubMed ID: 23684083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taboos and opportunities in sonothrombolysis for stroke.
    Alexandrov AV; Barlinn K
    Int J Hyperthermia; 2012; 28(4):397-404. PubMed ID: 22621740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteplase: new indication. Inadequately assessed in ischaemic stroke.
    Prescrire Int; 2004 Aug; 13(72):127-31. PubMed ID: 15532135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis for acute ischemic stroke.
    Hajjar K; Kerr DM; Lees KR
    J Vasc Surg; 2011 Sep; 54(3):901-7. PubMed ID: 21889708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating acute ischemic stroke.
    Fisher M; Bastan B
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reperfusion in acute ischaemic stroke: present and future].
    Herrera M; Gállego J; Muñoz R; Aymerich N; Zandio B
    An Sist Sanit Navar; 2008; 31 Suppl 1():31-46. PubMed ID: 18528442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
    Ciccone A; Valvassori L; Nichelatti M;
    Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making a case for acute ischemic stroke.
    Baldwin KA; McCoy SL
    J Pharm Pract; 2010 Oct; 23(5):387-97. PubMed ID: 21507844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
    Eissa A; Krass I; Bajorek BV
    J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
    Jahan R; Vinuela F
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovascular treatment of acute ischemic stroke: Honolulu shock and thereafter.
    Yoshimura S; Shirakawa M; Uchida K; Tanaka Y; Shindo S
    J Stroke Cerebrovasc Dis; 2014; 23(5):e295-8. PubMed ID: 24630827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society.
    Minematsu K; Toyoda K; Hirano T; Kimura K; Kondo R; Mori E; Nakagawara J; Sakai N; Shiokawa Y; Tanahashi N; Yasaka M; Katayama Y; Miyamoto S; Ogawa A; Sasaki M; Suga S; Yamaguchi T;
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):571-600. PubMed ID: 23727456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteplase and ischaemic stroke: have new reviews of old data helped?
    Lindley RI; Wardlaw JM; Sandercock PA
    Lancet Neurol; 2005 Apr; 4(4):249-53. PubMed ID: 15778104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging-based selection for intra-arterial stroke therapies.
    Morais LT; Leslie-Mazwi TM; Lev MH; Albers GW; Yoo AJ
    J Neurointerv Surg; 2013 May; 5 Suppl 1():i13-20. PubMed ID: 23572461
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolysis beyond 3 hours for acute ischaemic stroke.
    Selvaratnam R; Srirangalingam U; Ahmad S; Goulden P
    Emerg Med J; 2009 Oct; 26(10):756-7. PubMed ID: 19773512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.